NO20044628L - Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler - Google Patents

Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler

Info

Publication number
NO20044628L
NO20044628L NO20044628A NO20044628A NO20044628L NO 20044628 L NO20044628 L NO 20044628L NO 20044628 A NO20044628 A NO 20044628A NO 20044628 A NO20044628 A NO 20044628A NO 20044628 L NO20044628 L NO 20044628L
Authority
NO
Norway
Prior art keywords
cell surface
containing cell
surface recognition
immunoglobulin domains
recognition molecules
Prior art date
Application number
NO20044628A
Other languages
English (en)
Norwegian (no)
Inventor
Christine Power
Andrew Robert Davids
Richard Joseph Fagan
Christopher Benjamin Phelps
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20044628L publication Critical patent/NO20044628L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
NO20044628A 2002-04-30 2004-10-27 Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler NO20044628L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209884.6A GB0209884D0 (en) 2002-04-30 2002-04-30 Proteins
PCT/GB2003/001851 WO2003093316A2 (fr) 2002-04-30 2003-04-30 Molecule a reconnaissance de la surface des cellules contenant un domaine d'immunoglobuline

Publications (1)

Publication Number Publication Date
NO20044628L true NO20044628L (no) 2004-12-29

Family

ID=9935806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044628A NO20044628L (no) 2002-04-30 2004-10-27 Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler

Country Status (16)

Country Link
US (1) US7622555B2 (fr)
EP (1) EP1499640A2 (fr)
JP (1) JP2006502702A (fr)
KR (1) KR20050008699A (fr)
CN (1) CN1665840A (fr)
AU (1) AU2003229961B2 (fr)
BR (1) BR0309638A (fr)
CA (1) CA2483038A1 (fr)
EA (1) EA007985B1 (fr)
GB (1) GB0209884D0 (fr)
IL (1) IL164777A0 (fr)
MX (1) MXPA04010674A (fr)
NO (1) NO20044628L (fr)
RS (1) RS92704A (fr)
WO (1) WO2003093316A2 (fr)
ZA (1) ZA200408453B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326393D0 (en) * 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
EP1879610A1 (fr) * 2005-05-06 2008-01-23 Laboratoires Serono S.A. Utilisation d une molecule de reconnaissance d une surface cellulaire contenant un domaine d immunoglobuline pour le traitement de maladies
CN100402551C (zh) * 2006-04-14 2008-07-16 中国科学院长春应用化学研究所 β2-微球蛋白的抗原表位及应用
JP2010500978A (ja) 2006-08-17 2010-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスポリメラーゼインヒビター
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US7906117B2 (en) 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
DK2164514T3 (en) 2007-05-21 2017-02-27 Alderbio Holdings Llc Antibodies to IL-6 and its use
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
CN102740888B (zh) 2009-11-24 2016-10-12 奥尔德生物制药公司 Il-6抗体及其用途
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
CA2818813C (fr) 2010-11-23 2020-10-06 Alder Biopharmaceuticals, Inc. Anticorps anti-il-6 utilises pour le traitement de la stomatite
BR112018071285A2 (pt) 2016-04-20 2019-02-12 Regeneron Pharma célula, conjunto de vetores, vetor, sistema, e, método
CN107526942B (zh) * 2017-07-18 2021-04-20 中山大学 生命组学序列数据的反向检索方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
GB2331666A (en) * 1997-11-20 1999-05-26 Dsc Telecom Lp Subscriber Terminal for a Wireless Telecommunications System
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
WO2001054477A2 (fr) * 2000-01-25 2001-08-02 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
CA2296792A1 (fr) 1999-02-26 2000-08-26 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
EP1385883A2 (fr) * 2000-10-27 2004-02-04 Incyte Genomics, Inc. Proteines transmembranes
AU2002219974A1 (en) * 2000-11-16 2002-05-27 Incyte Genomics, Inc. Immunoglobulin superfamily proteins
EP1576116A4 (fr) 2002-07-12 2008-01-09 Nuvelo Inc Procede et materiaux se rapportant a de nouveaux polypeptides et polynucleotides
CA2500521A1 (fr) 2002-10-02 2004-09-23 Nuvelo, Inc. Nouveaux acides nucleiques et polypeptides

Also Published As

Publication number Publication date
EA007985B1 (ru) 2007-02-27
MXPA04010674A (es) 2005-02-17
BR0309638A (pt) 2005-03-01
CA2483038A1 (fr) 2003-11-13
KR20050008699A (ko) 2005-01-21
JP2006502702A (ja) 2006-01-26
EP1499640A2 (fr) 2005-01-26
IL164777A0 (en) 2005-12-18
WO2003093316A2 (fr) 2003-11-13
AU2003229961B2 (en) 2009-02-19
CN1665840A (zh) 2005-09-07
US20040204352A1 (en) 2004-10-14
GB0209884D0 (en) 2002-06-05
US7622555B2 (en) 2009-11-24
RS92704A (sr) 2006-12-15
EA200401453A1 (ru) 2005-06-30
AU2003229961A1 (en) 2003-11-17
ZA200408453B (en) 2006-07-26
WO2003093316A3 (fr) 2004-02-12

Similar Documents

Publication Publication Date Title
NO20044628L (no) Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler
AU2018358057B2 (en) Kits for analysis using nucleic acid encoding and/or label
WO2019089846A1 (fr) Méthodes et compositions pour analyse de polypeptides
WO2020223133A1 (fr) Procédés et réactifs pour le clivage de l'acide aminé n-terminal d'un polypeptide
DK1673475T3 (da) Sammensætninger til diagnose og terapi af sygdomme, som er forbundet med aberrant ekspression af futriner (R-Spondiner) og/eller Wnt
DE602004021836D1 (de) Meg1-endospermspezifische promotoren und gene
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
CN120604125A (zh) 使用二硫代酯和硫代氨基甲酰基氨基酸反应性基团的单分子肽测序
WO2025166050A1 (fr) Séquençage à base de nanopores de peptides
WO2008016385A3 (fr) Polypeptides désacylase, polynucléotides désacylase et leurs procédés d'utilisation
NO20070780L (no) Celloverflateprotein.
NO20052956L (no) Defensinprotiner
MX2007005054A (es) Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax.
EA200600956A1 (ru) Молекулы-антагонисты цитокинов
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
ATE402948T1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält
NO20053512L (no) IL-8-liknende proteiner
DE602004024300D1 (de) Anti-BAMBI Antikörper oder RNA zur Diagnose und Therapie bei Dickdarm- oder Leberkrebs
WO2004009633A8 (fr) Recepteur de serotonine
ATE340804T1 (de) Hyphenspezifische faktoren aus candida albicans
ATE512983T1 (de) Rezeptor für das tgr3-like protein
NO20052958L (no) Spleisevariant av humant placentalt veksthormon
WO2007049065A3 (fr) Proteine contenant des domaines vwfa, collagene et kunitz
NO20053574L (no) Spleisevarianter av LGR6
ATE454472T1 (de) C1ckb-mutation als diagnostisches und therapeutisches ziel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application